. Because ROS damage and mitochondrial dysregulation are prominent in aging and Alzheimer's disease (AD) and their relationship to the redox state is unclear, we wanted to know whether an oxidative redox shift precedes these markers and leads to macromolecular damage in a mouse model of AD. We used the 3xTg-AD mouse model, which displays cognitive deficits beginning at 4 months. Hippocampal/cortical neurons were isolated across the age span and cultured in common nutrients to control for possible hormonal and vascular differences. We found an increase of NAD(P)H levels and redox state in nontransgenic (non-Tg) neurons until middle age, followed by a decline in old age. The 3xTg-AD neurons maintained much lower resting NAD(P)H and redox states after 4 months, but the NADH regenerating capacity continuously declined with age beginning at 2 months. These redox characteristics were partially reversible with nicotinamide, a biosynthetic precursor of NAD ϩ . Nicotinamide also protected against glutamate excitotoxicity. Compared with non-Tg neurons, 3xTg-AD neurons had more mitochondria/neuron and lower glutathione (GSH) levels that preceded age-related increases in ROS levels. These GSH deficits were again reversible with nicotinamide in 3xTg-AD neurons. Surprisingly, low macromolecular ROS damage was only elevated after 4 months in the 3xTg-AD neurons if antioxidants were removed. The present data suggest that a more oxidized redox state and a lower antioxidant GSH defense can be dissociated from neuronal ROS damage, changes that precede the onset of cognitive deficits in the 3xTg-AD model.
Introduction
The brain depends on the redox reaction of nicotinamide adenine dinucleotide (reduced form; NADH) to transfer electrons to oxygen in the production of ATP by oxidative phosphorylation. Some of the electrons escape tight controls to reduce oxygen to O 2 . Ϫ , H 2 O 2 , OH · , and ONOO Ϫ , collectively called reactive oxygen species (ROS), which can damage macromolecules. With aging and in Alzheimer's disease (AD), ROS damages brain proteins (Butterfield et al., 1998; Hensley et al., 1998; Smith et al., 1998) , lipids (Montine et al., 1998) , and nucleic acids (Nunomura et al., 1999) , but determining whether these are a consequence of metabolic aging or are causal to AD has been elusive. The major electron transfer currencies for oxidation and reduction reactions in cells are the redox couples NADH/NAD ϩ and NADPH/ NADP ϩ . A reductive shift in redox is associated with cell proliferation, an oxidative shift with morbidity and apoptosis (Jones, 2006) . These principles led us to formulate the epigenetic oxidized redox shift (EORS) theory of aging (Brewer, 2010) and propose that an oxidized redox state is upstream of ROS generation. Here, we test the hypothesis that an age-related oxidized redox shift is upstream of elevated ROS levels and reported cognitive deficits. We determine the redox shift as intrinsic fluorescence of intracellular NADH (Chance and Williams, 1956; Chance et al., 1979) in isolated neurons with reference to the oxidized flavin nucleotide FAD (Parihar et al., 2008) . Given that 0.1 mM NADH is the major intracellular redox currency with eight times more free energy than ATP (Klaidman et al., 1995; Brewer, 2010) and millimolar glutathione (GSH) (Kudo et al., 1990 ) is the major redox buffer in cells (Das and White, 2002) , we further hypothesized that aging is associated with an oxidized redox state evident as an oxidative shift in the NAD(P)H/FAD redox ratio and a decline in GSH levels that precede elevations in ROS.
Nicotinamide, a biosynthetic precursor of NAD ϩ , was previously shown to increase NADH and NADPH levels in striatum and thalamus of whole-brain tissue of adult mouse (Klaidman et al., 2001) . However, the AD-and age-dependent effects of nicotinamide on neurons remain unclear. Nicotinamide also improved the cognitive deficits, which begin at 4 months, in a hippocampus-and amygdala-dependent task in a triple trans-genic mouse model of AD (3xTg-AD) (Oddo et al., 2003a,b) by selectively decreasing Thr231 phospho-tau, increasing stabilizing acetylated ␣-tubulin, and increasing synaptogenic p25, all associated with improved learning and memory (Green et al., 2008) . These findings led us to investigate whether nicotinamide could increase intracellular NAD(P)H levels and change the redox state in 3xTg-AD mice. We measured other possible events upstream of AD-like pathology, including cytochrome c release, GSH antioxidant defenses, and macromolecular damage in aging and in a male 3xTg-AD mouse model to determine the relationship between ROS damage and the onset of cognitive changes in these mice. We used cultured adult neurons (Brewer, 1997; Brewer and Torricelli, 2007) that enable age-related comparisons of neurons under common culture conditions that control or eliminate hormonal, vascular, and inflammatory changes present during aging in vivo.
Materials and Methods
Mouse model. We used LaFerla's triple transgenic mouse model of AD (3xTg-AD) with human transgenes APP (SWE), PS1 (M146V), and Tau (P301L) under the control of Thy1.2 promoters (Oddo et al., 2003b) . Nontransgenic (non-Tg) mice on the same mixed C57BL/6/129 background as the 3xTg-AD mice were used as controls. For all our experiments, we used male 3xTg-AD and non-Tg animals that were housed one to four per cage, fed rodent diet 5001 (LabDiet; Purina, with 28.5% calories from protein, 13.5% from fat, and 58% from carbohydrates) ad libitum at controlled temperature and humidity and a 12 h light/dark cycle. All animals underwent genotyping before experiments. DNA was extracted from tail snips using Roche High Pure PCR Template Preparation Kit. We used two primer sets for identifying the 3xTg-AD mutant. The following primers identified the PS1 gene: forward, 5Ј-CAC ACG CAA CTC TGA CAT GCA CAG GC-3Ј; reverse, 5Ј-AGG CAG GAA GAT CAC GTG TTC AAG TAC-3Ј (Invitrogen). The PCR product was digested with the restriction enzyme BstEII (New England BioLabs). Non-Tg mice showed a single band (ϳ550 bp), and 3xTg-AD mice showed two bands (ϳ300 and 250 bp). The following primers identified the hAPP gene: forward, 5Ј-GCT TGC ACC AGT TCT GGA TGG-3Ј; reverse, 5Ј-GAG GTA TTC AGT CAT GTG CT-3Ј. Non-Tg mice showed no amplification, and 3xTg-AD mice showed one band (ϳ300 bp).
Primary neuron culture. Adult hippocampal and cortical neurons were isolated from non-Tg and 3xTg-AD age-matched male mice at 2-, 4-, 8-, 11-, and 21-month time points (Brewer and Torricelli, 2007) . The combined hippocampus and frontal cortex of each hemisphere (ϳ140 mg of tissue) were sliced at 0.5 mm and combined in Hibernate A (BrainBits), 2% B27 supplement (Invitrogen), and 0.5 mM Glutamax (Invitrogen). The tissue was digested with 2 mg/ml papain (Worthington) for 30 min at 30°C. Slices were triturated, and the neurons were separated from debris and microglia on an Optiprep (Sigma-Aldrich) density gradient. To limit the toxicity caused by excess debris, each hippocampus and hemicortex was digested, triturated, and spun through a density gradient in separate tubes. After the gradient, the neuron-enriched fractions of each hippocampus and frontal cortex were combined. Viable cells were counted by exclusion of trypan blue. Neurons were plated at 32,000 cells/cm 2 on 12 and 15 mm glass coverslips (Assistant; Carolina Biological) that were coated overnight with poly-D-lysine, 100 g/ml in water. The cells were plated and cultured in Neurobasal A/B27/Glutamax (Invitrogen) with 10 ng/ml FGF2 and 10 ng/ml PGDFbb (Invitrogen) for trophic support. Cells were cultured for 7-12 d at 37°C in 5% CO 2 , 9% O 2 at saturated humidity (Forma).
Live-dead assay. For neuron survival, live cells on glass coverslips were stained with fluorescein diacetate (15 g/ml; Sigma-Aldrich), and dead cells were stained with propidium iodide (4.6 g/ml; Sigma-Aldrich) (Brewer et al., 1993) . After the slips were washed with HBSS (Invitrogen), cells were observed by blue and green fluorescence excitation through a 20ϫ objective (Olympus) for green and red fluorescence. Survival was calculated as the average percentage of live cells divided by the total cells (live plus dead) in 8 -12 adjacent fields.
NAD(P)H and FAD measurements from intrinsic fluorescence.
Single live cells were imaged for simultaneous NAD(P)H and FAD measurements as described previously (Parihar et al., 2008) with slight modification. Because our system cannot distinguish between NADH and NAD(P)H fluorescence, we use the more general term NADPH for our experiments. However, 80% of autofluorescence originates from NADH (Eng et al., 1989) , so we can assume that NADH contributes maximally to the NAD(P)H autofluorescence pool. Cells cultured for 8 d on 15 mm glass coverslips were mounted on a slip holder (Warner Instruments) in 500 l of Hibernate A Low Fluorescence (BrainBits) and 0.5 mM Glutamax. Hibernate A clamps the pH at 7.3 and contains the same amino acids, salts, and vitamins as the culture medium. Twenty micrometer polystyrene beads (Polysciences) were added to approximate the neuron diameter and to create a fixed space between two coverslips to reduce evaporation and provide a constant optical thickness; they also served as a focusing aid. Three hundred fifty nanometers of light were used to excite NADH using a 75 W Xenon arc lamp [Deltaram V (slits open two turns each); Photon Technology International] attached to a dual Photometer D104 controlled by Felix GX software (Photon Technology International) and observed under a Nikon 40ϫ oil objective. The dichroic used for simultaneously exciting NADH and FAD was a 450 dcxru (Nikon) in a Nikon Diaphot 300 microscope with a beam splitter having a 490 nm DCLP dichroic with 460 nm bandpass emitter filter (S460/36; Chroma) for NADH and a 490 nm long-pass filter for FAD. Because emission spectra for NADH and NADPH overlap, we use the general term NAD(P)H to indicate that fluorescence was generated from either or both nucleotides. The photomultiplier voltage for NAD(P)H was set at 1000 V, and for FAD it was set at 850 V. Each cell was isolated with a constant 20 m square slit and measured for 1 s every 6 s over 60 s. Five to six cells were imaged in a programmed order with the help of an automated stage (Ludl Electronic Products). To convert fluorescent intensities (counts/second) to micromolar concentrations, the system response was calibrated to a concentration curve (0 -200 M) of NAD(P)H and FAD (Parihar et al., 2008) . Background fluorescence was subtracted before results were analyzed for NAD(P)H, FAD concentration, and redox ratio (NAD(P)H/FAD).
To measure NADH regenerating capacity, we determined the difference between NADH in neurons with 5 M rotenone to block consumption at complex I (maximum) from NADH after treatment with 1 M oligomycin to block ATP synthase activity, followed by 1 M carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP) to uncouple the respiratory chain to drive maximum NADH consumption (minimum NADH).
Nicotinamide treatment. Nicotinamide (Sigma) was prepared in Neurobasal A, 0.5 mM Glutamax. Neurons were treated for 15-16 h with or without nicotinamide.
HPLC of adenine nucleotides. Extraction, derivatization, and analysis of brain NAD/NADH was adapted from Klaidman et al. (1995) . Anesthetized animals were decapitated into liquid nitrogen to rapidly quench all metabolism. Approximately 40 mg of combined hippocampus and cortex was dissected in Hibernate A (BrainBits) at 4°C. The tissue was weighed and homogenized in 5 l/mg 0.2 M KCN, 0.06 M KOH, 1 mM bathophenanthroline disulfonic acid (BPDS) (catalog #146617; Sigma) with a plastic pestle (K749520 -0000; Fisher Scientific) on ice and reacted for 5 min to produce stable cyanide derivatives of the adenine nucleotides. The derivatized homogenate was extracted with chloroform and centrifuged at 17,000 ϫ g for 5 min at 4°C. The upper layer was again extracted with chloroform and centrifuged. The aqueous portion was then filtered through a 0.45 m nylon filter (CoStar Spin-X; Corning) by centrifuging at 14,000 ϫ g for 10 min at 4°C. The filter tube was then rinsed with 30 l of 0.2 M KCN, 0.06 M KOH, and 1 mM BPDS, and was spun for an additional 5 min to recover residual sample. Samples were stored at Ϫ70°C until analysis. Before injection onto the column, samples were diluted with one-sixteenth part 1.6 M ammonium acetate, pH 6.0 (8ϫ mobile phase). An injection volume of 20 l was applied to a 250 ϫ 4.6 mm, 5 m ProteCol GP C18 125 reverse-phase column (SGE Analytical Science). Analytes were detected by fluorescence (excitation, 330 nm; emission, 460 nm) on a Waters Breeze 2 HPLC System. The mobile phase consisted of two solutions. Solvent A was 0.2 M ammonium acetate (Fisher Scientific), pH 6.0. Solvent B was 50% 0.2 M ammonium acetate, pH 6.0 and 50% HPLC grade methanol. A gradient of mobile phase began as 92% solvent A, 8% solvent B. After 1 min, solvent B was increased at a rate of 0.4% for 25 min. The flow rate was 1 ml/min. Freshly made 1.5 mM standards of NAD and NADH were diluted to 5-30 M with 0.2 M KCN, 0.06 M KOH, and 1 mM BPDS, and were reacted for 5 min. Derivatized standards were diluted with one-sixteenth part 1.6 M ammonium acetate, pH 6.0. We used the Nernst equation to calculate the redox state of the tissue, Eh ϭ E 0 Ϫ 2.3(RT/nF )log([NADH]/[NAD]), with the standard potential relative to hydrogen, E 0 ϭ Ϫ370 mV, the gas constant R ϭ 1.987 cal/(degree ϫ mol), T ϭ 310°K, n ϭ 1 electron transfer, and the Faraday constant F ϭ 23.062 cal/(mol ϫ mV).
Simultaneous measurement of ROS and glutathione in live cells. To determine ROS levels and antioxidant GSH defenses, we followed the protocol used before with few changes. At 8 d in culture, 100% of the media containing antioxidants in the B27 was replaced with Neurobasal A/Glutamax without B27 for 15 h at 37°C, 5% CO 2 , and 9% O 2 . Before experiments, cells attached to 15 mm glass coverslips were mounted in a slip holder in 800 l of Neurobasal A, Glutamax, and 20 M 2Ј,7Ј-dichlorofluorescein (DCF) diacetate (Invitrogen) for 20 min. During the last 5 min of DCF incubation, 100 M monochlorobimane (MCB, M1381; Invitrogen) was added to measure GSH (Hulbert and Yakubu, 1983) . After incubation, cells were rinsed twice with Hibernate A low fluorescence, Glutamax containing 4.6 g/ml propidium iodide (PI) to stain any dead cells. Dead cells were not included in the analysis because of their high ROS and low GSH signal. Cells were imaged through a 40ϫ objective/numerical aperture 0.60 using Olympus optics: 4,6-diamidino-2-phenylindole-2-HCl (DAPI filter for MCB), fluorescein isothiocyanate (FITC filter for DCF), and tetramethylrhodamine isothiocyanate (TRITC filter for PI). Image-Pro Plus software (version 7.0; Media Cybernetics) was used for analysis of fluorescence intensity.
Fura-2 calcium imaging in live neurons. Live adult neurons were imaged for intracellular calcium as described previously (Brewer et al., 2006) . Briefly, neurons were loaded with 5 M Fura-2-AM (Invitrogen) for 45 min in Krebs' buffer (100 mM NaCl, 20 mM KCl, 1 mM MgCl 2 , 1 mM CaCl 2 , 1 mM NaH 2 PO 4 , 4.2 mM NaHCO 3 , 10 mM glucose, 12.5 mM MOPS, pH 7.3) in 5% CO 2 , 9% O 2 , followed by de-esterification for 30 min in Krebs' buffer. Twenty to 30 neurons were imaged using Easy Ratio Pro software (Photon Technology International) and a CoolSnap HQ 25 (Photometrics) charge-coupled device camera. Fluorescence was excited alternately between 340 and 380 nm for 400 ms using a Fura-2/rhodamine filter (Chroma) and a Nikon 40ϫ oil objective.
Immunostaining of macromolecular damage in fixed cells. Neurons cultured for 8 d attached to 15 mm glass coverslips were fixed with 4% paraformaldehyde in PBS (minus magnesium and calcium) for 10 min. Then a blocking and permeabilization solution of 1% Triton X-100, 1% bovine serum albumin (BSA) in PBS was applied to the slips for 10 min. Primary antibodies, rabbit anti-OH-nonenal IgG (ALX-210 -767; Enzo Life Sciences), and mouse anti-8-OH-guanosine (QED Biosciences) were diluted with 0.02% Triton X-100, 1% BSA, in PBS 1:500 and 1:82.5, respectively. The primary antibodies were allowed to bind overnight at 4°C. Secondary antibodies Alexa Fluor 488 goat anti-rabbit (Invitrogen) diluted 1:300 and Alexa Fluor 568 goat anti-mouse (Invitrogen) diluted 1:2000 were allowed to bind for 1 h at room temperature. Bisbenzamide, final concentration 0.33 g/ml, was applied to slips for 2 min to label nuclei. Neurons used as a positive control were treated with 20 M hydrogen peroxide (H 2 O 2 ) for 10 min. Coverslips were mounted on a slide and imaged at 60ϫ with an oil-immersion objective using Olympus dichroic filters for DAPI (bisbenzamide), FITC (OH-nonenal), and TRITC (OH-guanosine). Image-Pro Plus software was used for analysis of fluorescence intensity with constant thresholds for each age and genotype. For experiments without antioxidants, neurons were cultured with B27 without antioxidants (Invitrogen). Total fluorescence per cell was calculated as fluorescence intensity ϫ area of cell (m 2 )/1000. Cytochrome c measurements. Neurons were rinsed with PBS and fixed with 4% paraformaldehyde in PBS (minus magnesium and calcium). After blocking with 3% BSA, 0.05% saponin in PBS, cytochrome c levels were detected using sheep anti-rabbit cytochrome c (Sigma; diluted 1:200) and Alexa Fluor 488 donkey anti-rabbit antibodies (Invitrogen; diluted 1:2000). Images were acquired at 100ϫ and analyzed using Image Pro Plus software. Images were segmented into bright and dim objects. The bright-intensity objects measured cytochrome c concentrated in mitochondria, while the dim-intensity objects measured the cytoplasmic cytochrome c.
Statistics. Data are presented as means and SEs. Student's t test was used to assess the difference of means using Prostat (Poly Software). We used p Ͻ 0.05 to reject the null hypothesis.
Results

No age-related loss of viability of neurons in culture
To evaluate neuron function with age, independent of an aging hormonal, immune, and vascular system, we isolated neurons from the frontal cortex and hippocampus of mice across their age span. Figure 1 shows that non-Tg ( Fig. 1 A) and 3xTg-AD ( Fig.  1 B) neurons in uniform culture medium have similar healthy morphology. There is also no difference between viability in non-Tg and 3xTg-AD neuronal cultures over the entire age span of the mouse. Neuronal viability does not decrease with age in uniform cultures (Fig. 1C) .
Determination of NAD(P)H concentrations and redox state with age and in 3xTg-AD mouse neurons
Given that brain deficit in the primary electron donor (NADH) to the electron transport chain would severely limit the capacity to generate ATP, we examined the NAD(P)H levels in isolated neurons as a function of age or AD-like genotype. Because autofluorescence of NADH cannot be distinguished from NAD(P)H in our system, we used the term NAD(P)H for our measurements. To determine the NAD(P)H concentration of non-Tg and 3xTg-AD cultured neurons, intrinsic fluorescence of NAD(P)H was measured microscopically from individual neurons with detection by split-beam photomultipliers to simultaneously measure the reduced NAD(P)H and the oxidized FAD. Figure 2 A shows the NAD(P)H concentration in live neurons from both non-Tg and 3xTg-AD mice at different ages, starting from sexual maturity at 2 months, through middle age at 11 months, and into old age at 21 months, near the median life span. In non-Tg mouse neurons (Fig. 2 A) , the NAD(P)H started at a low concentration (60 M) that rose 85% with development to 111 M at 11 months (middle age), after which the NAD(P)H concentration dropped 33% to 77 M in old age. Although 3xTg-AD mouse neurons started at the same NAD(P)H concentration as non-Tg mouse neurons (58 M), NAD(P)H concentration increased toward middle age by only 21%, then began to decline earlier after 8 months by 56% to 30 M in old age. The final NAD(P)H concentration in 3xTg-AD neurons was only 39% that of non-Tg neurons. and Williams, 1956; Chance et al., 1979) . The use of the FAD measure is necessitated by the nonfluorescent properties of NAD ϩ , while FAD and NAD(P)H exhibit intrinsic fluorescence microscopically measurable in single cells. Figure 2 B shows the ratio of reduced [NAD(P)H]/oxidized [FAD] (redox ratio) in neurons of both genotypes across the age span. In non-Tg neurons, the redox ratio mimics the NAD(P)H profile with a shift toward a reduced redox peak at middle age and an oxidized shift in old age. In contrast to non-Tg neurons, the redox ratio in the 3xTg-AD neurons declined continuously with age toward a 62% more oxidized redox state. These results suggest that the redox state of live single neurons varies with age and genotype in large, reproducible ways, with potential impact on numerous metabolic functions.
NADH regenerating capacity
Because aging and the 3xTg-AD genotype caused a lower NAD(P)H concentration and a more oxidized redox state, we wanted to investigate whether this lower NAD(P)H in 3xTg-AD neurons resulted from higher NADH consumption by complex I of the electron transport chain or from lower NADH regenerating capacity by lactate and pyruvate dehydrogenases and Krebs' cycle dehydrogenases compared with non-Tg neurons. Either way, the imbalance would produce a more oxidized redox state insufficient to withstand a challenge of oxidative stress. We compared NADH levels under two conditions. First, to minimize NADH levels and maximize consumption, we added oligomycin to block the reversal of ATPase and FCCP to dissipate the proton gradient and to maximally consume NADH by stimulation of complex I (NADH dehydrogenase), the major consumer of NADH for electron transport down the chain to oxygen. Second, we blocked complex I with 5 M rotenone to minimize NADH consumption and maximize NADH levels. At 2 months for both genotypes, the resting NADH levels were near those with FCCP added, indicating that the youngest neurons were operating near their maximum capacity to consume NADH. At all subsequent ages, the resting levels of NADH were near the midpoint between uncoupled FCCP levels and consumption-inhibited rotenone levels (Fig. 2C) .
The difference between the maximum and minimum NADH concentrations evoked by rotenone and FCCP provides a measure of the NADH regenerating capacity. Figure 2 D shows that both genotypes showed an increase in NADH regenerating capacity until middle age, after which they dramatically declined to similarly low levels in old age. Compared with non-Tg neurons, 3xTg-AD neurons showed significant deficits in NADH regenerating capacity from the earliest age of 2 months. However, this early deficit was amplified at 4, 8, and 11 months, suggesting that NADH regenerating capacity is further impaired with age. Because FCCP lowers NADH levels and rotenone raises NADH levels in all ages and both genotypes, complex I use is not impaired in either the 3xTg-AD or the non-Tg neurons.
Reversal of NAD(P)H and redox deficits with nicotinamide
Nicotinamide, a precursor of NAD ϩ (Ying, 2008) , reverses learning deficits in the 3xTg-AD mouse (Green et al., 2008 ) with a mechanism attributed to epigenetic changes based on acetylation of phospho-tau Thr231. Here, we consider an alternative mechanism in which nicotinamide is first an NAD ϩ and then an NADH precursor to supply more energy to neurons. Treatment of 21-month-old neurons with increasing doses of nicotinamide for 15 h produced an inverted U-response in neuron NAD(P)H levels and redox ratios (Fig. 3 A, B) . Two millimolar nicotinamide produced a maximum response. In 21-month-old non-Tg neurons, nicotinamide raised the [NAD(P)H] from 76 to 95 M and produced a reductive shift in the redox ratio from 4.3 to 5.4, increasing both concentration and redox ratio by 25% (Fig.  3 A, B) . Nicotinamide treatment of 21-month-old 3xTg-AD neurons led to an increase in [NAD(P)H] from 30 to 54 M and in the redox ratio from 1.8 to 2.5, leading to larger increases of 80% in NAD(P)H and 39% in the redox ratio, respectively, but it failed to restore these neurons to levels present in non-Tg neurons. Treatment of 11-month-old neurons with 2 mM nicotinamide produced non-Tg shifts from 110 to 129 M NAD(P)H and 3xTg-AD shifts from 68 to 109 M NAD(P)H. Treatment of 2-month-old neurons with 2 mM nicotinamide produced non-Tg shifts from 61 to 86 M NAD(P)H and 3xTg-AD shifts from 58 to 80 M NAD(P)H. To determine the effect of nicotinamide on regenerating capacity, we treated cells with FCCP and rotenone as before. We observed that in 21-month-old animals of both genotypes, nicotinamide treatment increased the maximal NADH (rotenone added) but had no effect on the minimal NADH levels (FCCP added) (Fig. 3C) . Similarly, treatment of 2-and 11-month-old neurons of either genotype with nicotinamide did not change the minimum NADH levels generated by FCCP (data not shown), suggesting complex I was not impaired in the 3xTg-AD neurons. However, as in Figure 3C for 21-month-old neurons and for 2-and 11-month-old neurons (data not shown), the maximum levels of NADH in the presence of rotenone were increased. The net results in Figure 3 , D and E, show the effect of 2 mM nicotinamide on the NADH regenerating capacity. At 2, 11, and 21 months, treatment with nicotinamide increased the regenerating capacity similarly for both 3xTg-AD and non-Tg neurons. These results suggest that NADH regenerating capacity is impaired in 3xTg-AD neurons but can be fully restored to non-Tg levels by 15 h treatment with nicotinamide at either 2 or 21 months.
Simultaneous changes in ROS levels and glutathione production in live neurons
Increased ROS levels is one of the major copathologies in aging and AD (Carney et al., 1994; Emerit et al., 2004) . Because an NAD(P)H oxidized redox state in 3xTg-AD neurons and in old non-Tg neurons also decreases its antioxidant ability, we wanted to determine the relationship between impaired NAD(P)H levels and ROS levels across the age span as well as simultaneous measures of the antioxidant buffer GSH. The oxidized redox state could result from increased ROS levels and/or decreased GSH defenses. We used fluorescent probes dichlorofluorescein diacetate (fluorescent product DCF) to detect ROS levels (Parihar and Brewer, 2007) and MCB to label GSH production (Hulbert and Yakubu, 1983) . Although DCF does not react directly with singlet oxygen, it can react with several reactive species such as OH · , NO 2 . Ϫ , and peroxynitrites (Kalyanaraman et al., 2012) and can damage macromolecules. ROS and GSH levels from live non-Tg and 3xTg-AD neurons from 8-month-old brains are shown in Figure 4 , A and B. Qualitatively, non-Tg neurons (Fig. 4 A) show stronger intensity of GSH label than 3xTg-AD neurons (Fig. 4 B) , with a merge as light blue neurons. The reverse was observed for ROS with non-Tg neuron levels low (Fig. 4 A) and higher intensity levels in 3xTg-AD neurons (Fig. 4 B) , with the merged image showing the stronger ROS green stain.
Compared quantitatively, the ROS levels of 3xTg-AD and non-Tg neurons began at low and equal levels at 2 and 4 months of age (Fig. 4C) . However, after 4 months, ROS levels increase sharply for both genotypes, with a significantly faster increase with age for 3xTg-AD than non-Tg neurons. The old-age level of ROS levels for non-Tg neurons was already attained at 8 months in the 3xTg-AD neurons. In the same cells, we simultaneously determined the levels of GSH as the primary cellular antioxidant buffer. We hypothesized that increased ROS would be buffered by increased GSH but that, in old age, either production of GSH would decline or more GSH would be consumed by even higher ROS. Further, we predicted that the 3xTg-AD neurons, with their increased energy demands from birth because of higher resting calcium levels, would reach this critical point of insufficient ROS buffering at an earlier age. Figure 4 D shows a significant deficit in GSH levels in 3xTg-AD neurons relative to non-Tg neurons starting at 2 months of age. Although both genotypes increased their GSH levels as ROS increased through middle age, the increase for 3xTg-AD neurons was significantly lower. Both genotypes produced lower levels of GSH from middle to old age, reaching levels below those at the start of life. Compared with non-Tg neurons, GSH levels in 3xTg-AD neurons remained significantly lower at all ages.
These simultaneous measures allow comparisons of the relative aging kinetics of increases in ROS and declines in GSH buffering of ROS. Focusing first on non-Tg neurons, Figure 4 E shows that GSH levels generally increase at the same rate as ROS levels until middle age. In old age, GSH levels decline much faster, creating an arbitrary crossover point at 17 months. In 3xTg-AD neurons, a similar crossover point occurs at only 7 months of age (Fig. 4 F) . The larger rise in ROS in the 3xTg-AD neurons from 4 to 11 months, compared with non-Tg neurons, may contribute to the failure of GSH to rise over this period. The further rise in ROS from 11 to 21 months in both genotypes, which correlates with a greater decline in GSH over this period, highlights the need for further studies regarding a threshold level of ROS, above which GSH is catastrophically consumed. This experiment suggests that 3xTg-AD deficits in GSH occur before excess ROS in 3xTg-AD neurons that become more acute as ROS levels increase and GSH buffers are consumed into middle age and old age.
Nicotinamide increased glutathione levels and decreased ROS levels in 3xTg-AD neurons
Because nicotinamide partially reversed the oxidative redox shift toward a reduced redox state and increased NAD(P)H concentration, we hypothesized that nicotinamide treatment would lower ROS levels by first increasing GSH regeneration from its oxidized form (GSSG) through NADPH-dependent GSH reductase followed by GSH reduction of H 2 O 2 by GSH peroxidase and other reactions. The first reaction may not be detectable by measuring GSH regeneration if a cell is at a steady-state equilibrium of GSH/GSSG. To test our hypothesis, we chose the 8 month time point because GSH levels in 3xTg-AD neurons declined after 8 months. Figure 5A shows that pretreatment with nicotinamide for non-Tg neurons did not alter GSH levels, whereas in 3xTg-AD neurons nicotinamide increased GSH levels by 30%. Simultaneous measures of ROS levels (Fig. 5B) revealed that non-Tg neurons did not alter their ROS levels in response to nicotinamide; treated 3xTg-AD neurons showed a 20% decrease in the ROS level. However, despite this significant decrease in ROS levels in 3xTg-AD neurons, the overall ROS levels remained significantly higher than in non-Tg neurons. One possible explanation for why ROS is not restored to the same levels as in non-Tg neurons is that other ROS sources remain unaffected by nicotinamide-enhanced NAD(P)H. In addition, the unaltered GSH levels in non-Tg neurons treated with nicotinamide suggest that non-Tg neurons are already regenerating enough GSH from GSSG to maintain a normal redox state.
Nicotinamide rescued cells from glutamate-induced excitotoxicity
Because glutamate excitotoxicity is implicated in aging and AD, we wanted to determine further whether nicotinamide can rescue neurons from glutamate-induced excitotoxicity. We chose our middle-aged (11-month) and old (21-month) animals to compare neuron viability. Figure 6 shows percentages dead in 11-month-old (Fig. 6 A) and 21-month-old (Fig. 6 B) neurons of both genotypes with 100 M glutamate and 2 mM nicotinamide treatment. Compared with untreated neurons, glutamate treatment induced a twofold increase in death in both non-Tg and 3xTg-AD neurons. However, cotreatment with nicotinamide and glutamate largely protected neurons from glutamate excitotoxicity ( p Ͻ 0.001 for 11 months; p Ͻ 0.02 for 21 months). Although nicotinamide reduced glutamate toxicity in non-Tg neurons to the level in untreated neurons, the treatment reduced by only 50% the toxicity in 21-month-old 3xTg-AD neurons. This increased susceptibility of 3xTg-AD neurons to glutamate toxicity suggests that factors other than NAD(P)H and GSH are involved in AD-like toxicity because these neuroprotectants appear to be fully restored by nicotinamide.
Calcium dysregulation in adult 3xTg-AD neurons 3xTg-AD neurons have threefold to fivefold higher intracellular calcium concentrations (Smith et al., 2005a; Stutzmann et al., 2006) at birth than non-Tg neurons. To confirm calcium dysregulation in adult neurons, we performed intracellular calcium imaging of 11-month-old non-Tg and 3xTg-AD neurons. We found that while the [Ca] i in non-Tg neurons was 109 nM, 3xTg-AD neurons had more than twofold higher [Ca] i at 253 nM (data not shown), which confirmed the previous study in primary neurons, cultured from 8-to 12-month-old 3xTg-AD mice (Lopez et al., 2008) .
Mitochondrial and cytoplasmic cytochrome c levels increase with age and AD genotype
Mitochondrial function is impaired in both aging and AD. However, it remains unanswered whether mitochondrial dysfunction . E, To better compare the effect of age for each genotype, in non-Tg neurons, ROS and GSH levels increase in parallel until middle age, after which GSH levels decline. F, In 3xTg-AD neurons, ROS levels increase to a greater extent than they do in non-Tg neurons, and GSH production plateaus at an early age, 4 months, before declining after middle age. N ϭ 3-4 mice per genotype and age.
causes the rise in ROS and oxidative shift in redox or whether ROS causes the mitochondrial dysfunction and oxidative shift. One line of evidence for causation is precedence: if event A precedes event B, then B cannot cause A. In our model system, to hypothesize that mitochondrial dysfunction causes a redox shift, early changes in mitochondrial function such as NADH regenerating capacity would precede redox changes and/or ROS. Given that healthy mitochondria retain and stressed mitochondria release cytochrome c, we determined the effect of age and genotype on neuronal and mitochondrial health.
According to hypothesis A, the increased genotypic stress on mitochondria causes increased release of cytochrome c from mitochondria into the cytoplasm with age. Examination of the mean cytoplasmic cytochrome c in Figure 7A shows low levels at 2 months followed by increased cytoplasmic levels in non-Tg and even higher levels in 3xTg-AD neurons at middle age that remained high at old age. This increase in cytoplasmic cytochrome c could lead to apoptosome activation. Hypothesis B was that 3xTg-AD neurons have fewer healthy mitochondria because they are poisoned by the excess ␤-amyloid and calcium so that those remaining have to work harder. A corollary is that harder working mitochondria produce more ROS and/or consume more NADH. In contradiction to this hypothesis, Figure 7B shows a higher mitochondrial count per cell in 3xTg-AD neurons than in non-Tg neurons in early and middle age. These results suggest that the 3xTg-AD neurons compensate for the increased genotypic stress by upregulating mitochondria in each cell. Higher measures of mitochondria per cell in 3xTg-AD compared with non-Tg neurons supports a compensatory bioenergetic mechanism in 3xTg-AD neurons. This higher mitochondrial count per cell in 3xTg-AD neurons is closely paralleled in Figure 7C by a higher early and middle-age intensity of bright-level cytochrome c immunoreactivity in the 3xTg-AD neurons than in the non-Tg neurons, likely associated with mitochondria.
Macromolecular damage in neurons with age
If ROS levels increase with age or genotype beyond the detoxification ability of the cell, then nucleic acid and lipid macromolecular damage will occur (Reed et al., 2009 ). To assess ROS-induced macromolecular damage in these cultured neurons as a function of mouse age and genotype, Figure 8 A shows 11-month-old neurons double stained for oxidative damage to DNA and RNA using anti-8-OH-(deoxy)guanosine and for lipid peroxidation using anti-4-hydroxynonenal in the same neurons. To demonstrate the reliability of these probes and cellular responses, we also treated 4-month-old neurons with 20 M H 2 O 2 for 10 min to induce excess oxidative damage to the cells (positive control). Probes for both nucleic acid damage and lipid peroxidation dramatically increased after the H 2 O 2 treatment. Despite an increase in ROS and oxidized redox state shown in Figures 4C and 2 B, we see in Figure 8 , B and C, no indication of ROS-induced macromolecular damage in cultured neurons with age or genotype. This suggests that the antioxidants in the cells and in the culture medium were sufficient to protect against significant ROS damage to macromolecules. As an additional control, we removed the superoxide dismutase (SOD), catalase, GSH, vitamin E acetate, and vitamin E from the culture medium. This external manipulation was sufficient to elicit both nucleic acid and lipid damage to 3xTg-AD neurons above those of non-Tg neurons from 4-month-old brains, whereas the 2-month-old neurons did not show any genotypic difference even with antioxidant removal (Fig. 8 E) .
NADH concentration and redox ratio in whole brain
To observe the redox state of brain tissue in vivo, which includes neurons with the support of other surrounding cell types, we analyzed hippocampal and cortical brain lysates by HPLC. Figure  9A shows a 22% decrease in NADH concentration in the 2-month-old 3xTg-AD brain. The redox state of the 3xTg-AD brain of 2-month-old animals ( Fig. 9B ) was significantly more oxidized (Ϫ372 mV) than that of the non-Tg brain (Ϫ387 mV). These results indicate that the redox state in the whole 3xTg-AD brain reflects an oxidative shift seen in the cultured neuron model.
Discussion
The ability of neurons of old animals to regenerate in culture and their lack of abundant ROS damage argue against the theory that aging results from an irreversible lifelong buildup of ROS damage. Nevertheless, neurons from old non-Tg and 3xTg-AD mice showed deficits in NAD(P)H levels, lower capacity to generate NAD(P)H, lower GSH levels, late elevated ROS, and failure to increase mitochondria to meet these energy demands. These aging effects indicate an early oxidized redox shift before ROS damage to macromolecules. Further, because of the rapid reversibility by nicotinamide of the oxidized redox shift and glutamate toxicity in neurons from old animals, we argue that processes associated with aging cause an important metabolic shift in reductive supply of energy as NADH to the electron transport chain. We (Brewer, 2010) and others (Anderson and Weindruch, 2010; Martin et al., 2010; Safdar et al., 2010) have hypothesized that a sedentary lifestyle causes this metabolic shift.
Regarding the AD model, we demonstrated that the redox ratio in the 3xTg-AD neurons never increased beyond 2-month levels and that NAD(P)H levels never increased above those of 4-month-old non-Tg neurons. Therefore, we predicted that restoration of NAD(P)H levels would reverse the low energetic capacity. Given that these genotype deficits could be reversed in Ͻ24 h with the NAD ϩ precursor nicotinamide, we argue that the age-related shift in redox state is a critical target that the AD-like transgenes exacerbate beyond normal aging. Further, the 3xTg-AD model shows impairment in GSH regeneration from 2 months on, never reaching levels of middle-age non-Tg neurons. Therefore, the supply of the key metabolites NADH and GSH Figure 7 . Cytoplasmic and mitochondrial distributions of cytochrome c (Cyto) immunoreactivity are both higher in 3xTg-AD than in non-Tg neurons. A, Cytoplasmic levels of cytochrome c increase from early (2 months) to middle age (11 months) but are higher in 3xTg-AD neurons at middle age and older age. B, The numbers of bright intracellular objects (individual and clusters of mitochondria) are elevated at all ages in 3xTg-AD compared with non-Tg neurons and increase from early to middle age. C, The intensity of these bright objects follows a similar pattern of higher levels in the 3xTg-AD than in the non-Tg neurons at early age and middle age: 3xTg-AD (filled circles); Non-Tg (open circles) . N Ͼ 60 neurons for two mice at 2 months. N Ͼ 89 neurons for three mice at 11 and 21 months for each genotype.
may restore sufficient reducing energy and antioxidant capacities to counter the impact of increased transgene expression.
These results support the novel proposition that an oxidative redox shift precedes increased ROS damage, cell damage, and cognitive decline with age, and in a mouse model of AD. In the absence of ROS damage, we found a robust oxidative shift in NAD(P)H in non-Tg old age that began earlier in the 3xTg-AD neurons. The capacity to generate NADH under stress showed substantial deficits in 3xTg-AD neurons beginning at 2 months of age. Compared with the non-Tg neurons from the earliest age (2 months), we also found 3xTg-AD neurons deficient in GSH, which continued throughout the age span. Both NAD(P)H and GSH levels declined in old age in both genotypes. We also observed that in 2-month-old brain extracts, 3xTg-AD neurons had a significantly lower NADH concentration and a more oxidized redox state than the non-Tg neurons. ROS levels were low before 8 months for both genotypes then increased until middle age, but increases were again reversible with nicotinamide. Surprisingly, macromolecular ROS damage was not detected with age or genotype in our in vitro model, unless environmental antioxidants were removed (reduced GSH, vitamin E, vitamin E acetate, catalase, and SOD). However, in brain extracts, malondialdehyde, hydroxynonenal, and thiobarbituric acid reactive substances levels were elevated in the 3xTg-AD relative to non-Tg mouse (Resende et al., 2008) . This observation, together with elevated SOD and GSH peroxidase, suggests an insufficient antioxidant response in the 3xTg-AD brain in vivo. Interestingly, oxidized GSH was increased and the enzyme to recycle to GSH, GSH reductase, was not increased in the 3xTg-AD brain. These observations could be related to our studies because NADPH is a cofactor for GSH reductase in the regeneration of GSH from GSSG. Thus, our measures of lower NAD(P)H in the 3xTg-AD neurons would deny sufficient reducing power to the enzyme needed to recycle the GSSG to GSH and to maintain redox balance. If the extracellular antioxidants were removed, 3xTg-AD neurons have significantly higher oxidative damage than non-Tg neurons, as in whole brain.
Several factors could contribute to a decreased NAD(P)H state and an oxidized redox state with age and an AD-like genotype, including the downregulation of TCA cycle enzymes that generate NADH (Bubber et al., 2005) , the lower rates of glycolysis with age (Patel and Brewer, 2003) and AD (Hoyer et al., 1988 (Hoyer et al., , 2005 , and the higher energy demands with age and genotype. In addition to glyceraldehyde-3-phosphate dehydrogenase in glycolysis, important sources of NADH are pyruvate dehydrogenase at the entry to the TCA cycle and within the TCA cycle, isocitrate dehydrogenase, ␣-ketoglutarate dehydrogenase, and malate dehydrogenase. Downregulation of any of these enzymes could be responsible for the decreased NADH levels in the 3xTg-AD neuron (Bubber et al., 2005) . Yao et al. (2009) observed a significant decline in pyruvate dehydrogenase (PDH) and cytochrome c oxidase (COX) activity in mitochondria isolated from 9-and 12-month-old 3xTg-AD brains compared with non-Tg brains. The levels of PDH protein were also significantly lower in 3xTg-AD brains from the young age of 3 months to the middle age of 12 months, whereas COX levels were significantly lower than in non-Tg brains at 9 and 12 months. In younger embryonic neurons from 3xTg-AD mice, maximum respiration stimulated by FCCP was impaired in the 3xTg-AD mice compared with the non-Tg mice (Yao et al., 2009 ). Thus, the availability of NADH for electron transfer is restricted in the 3xTg-AD mouse. In neu- Figure 8 . Absence of ROS-induced macromolecular damage in neurons in the presence of antioxidants and only elevated after 4 months in the 3xTg-AD neurons if antioxidants were removed. A, Eleven-month-old non-Tg and 3xTg-AD neurons cultured in B27 (with antioxidants) were fixed with paraformaldehyde and probed for 8-hydroxy-(deoxy)guanosine (8-OH dG) (top) and 4-hydroxynonenal (HNE) (middle); merged image (bottom). B, C, No significant differences in macromolecular damage were seen with age or genotype. A positive control treated with 20 M H 2 O 2 (closed triangle) indicates sensitivity of the measures to high levels of oxidation. D, In B27 without antioxidants, 4-month-old non-Tg and 3xTg-AD neurons indicated an increase in 8-OH dG (top) for both genotypes, but for HNE (middle), only the 3xTg-AD neurons increased immunoreactivity; merged image (bottom). E, Without antioxidants (ϪAO), macromolecular damage was unchanged with genotype at 2 months but was higher at 4 months in 3xTg-AD (closed bars) than in non-Tg neurons (open bars) for both 8-OH dG (left) and HNE (right). N Ͼ 200 neurons from two to four mice per condition.
rons of aged rats, our laboratory has also shown by flux control analysis of the electron transport chain that respiration was limited at the substrate level (NADH) for the NADH-ubiquinone oxidoreductase (Jones and Brewer, 2010) . Consequently, a more oxidized environment will contribute to higher rates of ROS generation. This corresponds to our result of decreased NAD(P)H capacity and excessive ROS after middle age.
Nicotinamide, a biosynthetic precursor of NAD ϩ , was previously shown to increase NADH and NADPH levels in striatum and thalamus of whole-brain tissue of adult mouse (Klaidman et al., 2001) . Nicotinamide also improved cognitive deficits in hippocampus-and amygdala-dependent tasks in 3xTg-AD mice associated with decreased Thr231 phosphotau, increased levels of the stabilizing form of acetylated ␣-tubulin, and increased synaptogenic p25, with improved learning and memory (Green et al., 2008) . In our study, we found that nicotinamide can, in fact, improve earlier agerelated deficits in NAD(P)H concentration, improve the redox ratio to a more normal reduced level, and increase NADH regenerating capacity. 3xTg-AD mice have an elevated intracellular Ca 2ϩ concentration from birth because of the mutant presenilin (Smith et al., 2005b; Stutzmann et al., 2006) , supporting the hypothesis that elevated calcium level contributes to AD (Khachaturian, 1994; Mattson et al., 2000) . Calcium can disrupt the mitochondrial membrane potential and increase opening of the mitochondrial transition pore, precipitating cell death. Physiologically elevated calcium also upregulates the NADHgenerating TCA cycle enzyme, ␣-ketoglutarate dehydrogenase (KGDH), in a concentration-related manner (Lai and Cooper, 1986) . However, at higher concentrations, calcium inhibits KGDH activity. Thus, age-related elevated calcium level in 3xTg-AD neurons could downregulate KGDH activity with less NADH generation. Although NAD(P)H acts as redox energy currency, GSH acts as a dynamic redox energy buffer (Das and White, 2002) with millimolar concentrations in rat brain (Kudo et al., 1990; Das and White, 2002) compared with micromolar concentrations of NADH (Gupte et al., 2005 ). An age-related decrease in GSH is associated with neurodegenerative diseases such as Parkinson's disease and AD (Schulz et al., 2000) , which could contribute to increased ROS levels. It is possible that 3xTg-AD neurons are unable to generate more GSH because of the decline in NAD(P)H and eventually cannot keep up with higher ROS levels. The reversal of low NAD(P)H, GSH, and high ROS levels in 8-month-old 3xTg-AD neurons by nicotinamide suggests that these redox agents are interlinked.
Cytochrome c is an essential electron carrier in the mitochondrial respiratory chain. We observed that at 2 months, 3xTg-AD neurons already had a significantly higher number of mitochondrial cytochrome c than did non-Tg neurons. Interestingly, though the mitochondrial count per neuron was high in 3xTg-AD neurons, the NAD(P)H concentration was the same for both non-Tg and 3xTg-AD neurons. The higher mitochondrial count in 3xTg-AD neurons may be needed to compensate for the inefficiency in ATP generation caused by elevated calcium levels (Nicholls, 2009) or amyloid-␤ exposure (Alberdi et al., 2010) , either of which would depolarize the mitochondrial membrane potential to lower energy to drive ATP synthesis. However, with age, 3xTg-AD mitochondria have lower NAD(P)H concentrations, suggesting that a depolarized membrane potential drives higher rates of NADH-ubiquinone oxidoreductase that lower NADH without sufficient regeneration.
Here, we were able to show that an oxidized redox state (NAD(P)H/FAD), lower NADH regenerating capacity, and lower GSH levels precede excessive ROS in 3xTg-AD compared with non-Tg neurons, a clear effect of redox changes with age on the intrinsic physiology of neurons from the AD model. We also showed that macromolecular damage in neurons was higher in 3xTg-AD neurons when antioxidants were removed from the culture media, but not until 4 months of age. Nicotinamide, which was previously shown to increase NADPH in mouse brain, could also reverse the oxidized redox state to a more reduced state, increase GSH levels, and decrease ROS levels in the neurons. In elegant studies in rats virally transfected with either SOD1 or catalase, age-related learning deficits were also dissociated from accumulated damage (Lee et al., 2011) . Because increased ROS levels and macromolecular damage along with decreased GSH levels are hallmarks of AD, any reversal and possible prevention of this damage with nicotinamide may have clinical significance. 
